Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 5:15 PM View:  | Gloria Melanie Chief Operating Officer | Immunovant, Inc. (IMVT) | 18-Nov-24 | Grant | 109,956 | -- | -- | 100% 0 to 109.96K | |
| 11-Oct-24 4:02 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 09-Oct-24 | Private Sale | 4,460 | $29.56 | $131,838.00 | (< 1%) 1.01M to 1.0M | |
| 11-Oct-24 4:04 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 09-Oct-24 | Private Sale | 5,162 | $29.56 | $152,589.00 | (2%) 343.78K to 338.61K | |
| 23-Aug-24 4:11 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 21-Aug-24 | Private Sale | 3,768 | $31.86 | $120,045.00 | (1%) 347.54K to 343.78K | |
| 23-Aug-24 4:15 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 21-Aug-24 | Private Sale | 3,295 | $31.86 | $104,976.00 | (< 1%) 333.39K to 330.1K | |
| 23-Aug-24 4:07 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 21-Aug-24 | Private Sale | 15,068 | $31.86 | $480,052.00 | (1%) 1.02M to 1.01M | |
| 23-Aug-24 4:10 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 21-Aug-24 | Private Sale | 3,027 | $31.86 | $96,437.30 | (< 1%) 443.99K to 440.96K | |
| 23-Aug-24 4:14 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 21-Aug-24 | Private Sale | 3,027 | $31.86 | $96,437.30 | (< 1%) 371.36K to 368.33K | |
| 26-Jul-24 4:17 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 24-Jul-24 | Private Sale | 4,015 | $27.76 | $111,456.00 | (1%) 337.41K to 333.39K | |
| 26-Jul-24 4:19 PM View: | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 24-Jul-24 | Private Sale | 3,456 | $27.76 | $95,938.60 | (2%) 141.62K to 138.16K | |
| 26-Jul-24 4:20 PM View: | Stout Jay S Chief Technology Officer | Immunovant, Inc. (IMVT) | 24-Jul-24 | Private Sale | 2,813 | $27.76 | $78,088.90 | (2%) 147.74K to 144.93K | |
| 19-Jul-24 5:36 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 17-Jul-24 | Private Sale | 8,685 | $29.69 | $257,887.00 | (< 1%) 1.03M to 1.02M | |
| 19-Jul-24 5:38 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 17-Jul-24 | Private Sale | 2,867 | $29.69 | $85,131.70 | (< 1%) 446.85K to 443.99K | |
| 19-Jul-24 5:41 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 17-Jul-24 | Private Sale | 3,044 | $29.69 | $90,386.10 | (< 1%) 374.4K to 371.36K | |
| 19-Jul-24 5:39 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 17-Jul-24 | Private Sale | 3,123 | $29.69 | $92,733.20 | (< 1%) 350.67K to 347.54K | |
| 19-Jul-24 5:42 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 17-Jul-24 | Private Sale | 2,505 | $29.69 | $74,382.00 | (< 1%) 339.91K to 337.41K | |
| 10-Jul-24 5:04 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 09-Jul-24 | Private Sale | 4,619 | $28.06 | $129,609.00 | (< 1%) 1.04M to 1.03M | |
| 10-Jul-24 5:06 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 09-Jul-24 | Private Sale | 1,527 | $28.06 | $42,847.60 | (< 1%) 448.38K to 446.85K | |
| 10-Jul-24 5:07 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 09-Jul-24 | Private Sale | 4,747 | $28.06 | $133,201.00 | (1%) 355.41K to 350.67K | |
| 24-May-24 4:13 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 22-May-24 | Private Sale | 3,247 | $29.65 | $96,273.50 | (< 1%) 377.65K to 374.4K | |
| 24-May-24 4:10 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 22-May-24 | Private Sale | 3,242 | $29.65 | $96,125.30 | (< 1%) 343.16K to 339.91K | |
| 24-May-24 4:15 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 22-May-24 | Private Sale | 16,163 | $29.65 | $479,233.00 | (2%) 1.05M to 1.04M | |
| 24-May-24 4:14 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 22-May-24 | Private Sale | 3,247 | $29.65 | $96,273.50 | (< 1%) 451.63K to 448.38K | |
| 24-May-24 4:18 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 22-May-24 | Private Sale | 4,042 | $29.65 | $119,845.00 | (1%) 359.46K to 355.41K | |
| 26-Apr-24 5:18 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 3,963 | $28.90 | $114,531.00 | (1%) 347.12K to 343.16K | |
| 26-Apr-24 5:22 PM View: | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 3,261 | $28.90 | $94,242.90 | (2%) 144.88K to 141.62K | |
| 26-Apr-24 5:20 PM View: | Stout Jay S Chief Technology Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 7,239 | $28.90 | $209,207.00 | (5%) 154.98K to 147.74K | |
| 19-Apr-24 5:57 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 34,079 | $29.06 | $990,269.00 | (3%) 1.09M to 1.05M | |
| 19-Apr-24 5:59 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 10,115 | $29.06 | $293,923.00 | (2%) 461.74K to 451.63K | |
| 19-Apr-24 6:01 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 12,253 | $29.06 | $356,049.00 | (3%) 371.71K to 359.46K | |
| 19-Apr-24 6:05 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 8,280 | $29.06 | $240,602.00 | (2%) 385.93K to 377.65K | |
| 19-Apr-24 6:06 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 9,827 | $29.06 | $285,554.00 | (3%) 356.95K to 347.12K | |
| 10-Apr-24 4:16 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 1,053 | $31.18 | $32,832.50 | (< 1%) 462.8K to 461.74K | |
| 10-Apr-24 4:18 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 3,689 | $31.18 | $115,023.00 | (< 1%) 375.4K to 371.71K | |
| 10-Apr-24 4:14 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 4,807 | $31.18 | $149,882.00 | (< 1%) 1.09M to 1.09M | |
| 04-Apr-24 4:46 PM View: | Pande Atul Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 11% 103.16K to 114.41K | |
| 04-Apr-24 4:48 PM View: | Migausky George V Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 109.81K to 121.06K | |
| 04-Apr-24 4:39 PM View: | Stout Jay S Chief Technology Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 55% 100.0K to 154.98K | |
| 04-Apr-24 4:50 PM View: | Hughes Douglas J. Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 113.75K to 125.01K | |
| 04-Apr-24 4:34 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 17% 330.95K to 385.93K | |
| 04-Apr-24 4:44 PM View: | Torti Frank Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 120,400 | -- | -- | 23% 515.27K to 635.67K | |
| 04-Apr-24 4:37 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 18% 301.97K to 356.95K | |
| 04-Apr-24 4:54 PM View: | Fromkin Drew J Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 13% 88.66K to 99.91K | |
| 04-Apr-24 4:23 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 160,534 | -- | -- | 17% 931.23K to 1.09M | |
| 04-Apr-24 4:29 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 13% 407.82K to 462.8K | |
| 04-Apr-24 4:31 PM View: | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 61% 89.9K to 144.88K | |
| 04-Apr-24 4:27 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 17% 320.42K to 375.4K | |
| 23-Feb-24 4:16 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,221 | $36.15 | $80,289.20 | (< 1%) 333.17K to 330.95K | |
| 23-Feb-24 4:18 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,134 | $36.15 | $77,144.10 | (< 1%) 304.1K to 301.97K | |
| 23-Feb-24 4:11 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 13,454 | $36.15 | $486,362.00 | (1%) 944.68K to 931.23K |
